글로벌 세포 기반 분석 시장 – 2029년까지의 산업 동향 및 예측

글로벌 세포 기반 분석 시장 분석 및 규모

수년에 걸쳐, 시장은 기술적으로 진보된 제품의 혁신과 연구에 대한 연구 및 개발 지출 증가로 인해 세포 기반 분석의 눈에 띄는 개선을 보였습니다. 시장은 예상 기간 동안 상당히 확대될 것으로 예상됩니다.

• 글로벌 세포 기반 분석 시장은 2021년에 189억 달러 규모였으며, 2029년까지 329억 6천만 달러에 도달할 것으로 예상되며, 2022-2029년 예측 기간 동안 7.2%의 CAGR을 기록할 것으로 예상됩니다. "약물 발견"은 생물제약 회사의 연구 개발 투자 증가로 인해 예측 기간 동안 세포 기반 분석 시장에서 가장 큰 응용 분야를 차지합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

글로벌 세포 기반 분석 시장 정의

세포 기반 분석은 효능 및 작용 기전과 같은 의약품의 세포독성 및 생물학적 테스트에 사용되는 기술입니다. 샘플에서 살아있는 세포와 죽은 세포의 양을 결정하는 균질적 접근 방식입니다. 세포 기반 분석은 약동학 및 약력학과 같은 다양한 특성을 사용하여 살아있는 세포를 분석하는 데 사용됩니다. 세포 기반 분석은 특히 항체 기능이나 세포 세트에 대한 치료 효능과 같은 특정 세포 기능을 이해하기 위한 연구에서 의료 연구 및 개발에서 유연한 도구로 발전했습니다.

세포 기반 분석 시장 동향

이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래와 같이 자세히 논의됩니다.

운전자

• 세포 기반 분석에 대한 선호도 증가

그들은 생화학적 분석과 달리 생물학적으로 관련성 있는 미세환경에서 일관된 조직 특이적 반응을 제공합니다. 게다가, 약물 개발에서 선도적인 식별 및 최적화 절차 덕분에 제약 및 생명공학 회사는 세포 기반 분석을 채택하고 있으며, 이는 이 시장의 성장을 이끄는 가장 중요한 요인입니다.

또한, 질병 발생 위험 증가(돼지 독감, COVID-19 등)와 연구 활동 수의 증가도 시장 성장을 촉진할 것으로 예상됩니다. 낮은 노동비와 원자재 비용, 약물 발견 서비스를 제공하는 CRO 수의 증가도 시장 성장을 완화할 것으로 예상됩니다.

게다가 세포 기반 검정의 최종 사용 부문에서의 기술적 발전과 새로운 약물의 도입은 시장에 수익성 있는 기회를 창출할 것으로 추정됩니다. 약물 발견 프로젝트의 성장과 약물 후보를 개발하기 위한 협업과 같은 전략적 접근 방식의 채택은 미래에 세포 기반 검정 시장의 성장률을 더욱 확대할 것입니다.

제약/도전 과제 글로벌 세포 기반 분석 시장

• 악기의 높은 비용

이러한 값비싼 시스템을 사용함에 따라 생물제약품 의 전체 생산 비용이 상당히 증가했습니다. 계측기의 높은 가격은 낮은 적응력으로 인해 투자 수익률(ROI)을 감소시켜 시장 성장을 방해할 것으로 예상됩니다.

• 전문가 부족

또한, 숙련된 전문가의 부족으로 인해 2022~2029년 예측 기간 동안 세포 기반 분석 시장이 어려움을 겪을 것으로 예상됩니다.

This cell based assays market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cell based assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Cell Based Assays Market

The cell based assays market was moderately impacted by the outbreak of COVID-19. Even though there were imposition of the government's lockdown and social distancing restrictions to curb the COVID-19 pandemic outbreak, the vaccine-related research in pharmaceutical and biotechnological firms, research centers, and university research institutions is regarded critical, and operations and production have been significantly unaffected. The functional efficiency of the antibodies generated to neutralise the target virus is assessed for both vaccinations and treatments. Cell-based assays are used to reduce the time and boost the throughput of these experiments. As a result, the need for cell-based tests to offer an early indication of the toxicity features of drug candidates has skyrocketed.

The availability of research funds and the demand for and manufacture of cell-based test products are predicted to expand as a result of the increased research activity. The rising need for COVID-19 research has provided a wide scope for cell-based 45 tests in viral infection research, vaccine development, and overall drug discovery.

Recent Developments

• In December 2020, Phitonex, Inc., a company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology, and immunology research, has been acquired by Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher will be able to offer more flow cytometry and imaging multiplexing capabilities thanks to Phitonex's product offering, which will help them meet changing customer needs in protein and cell analysis research.

Global Cell Based Assays Market Scope

The cell based assays market is segmented on the basis of type, product and services, technology, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Cell Viability Assay
• Cytotoxicity Assay
• Cell Death Assay
• Cell Proliferation Assay
• Others

On the basis of type, the cell based assays market is segmented into cell viability assay, cytotoxicity assay, cell death assay, cell proliferation assay and others.

Product and Services

• Consumables
• Services
• Instruments
• Software

On the basis of product and services, the cell based assays market is segmented into consumables, services, instruments and software. The consumables are sub-segmented into reagents and assay kits. Assay kits are also further sub-segmented into reporter gene assays, cell growth assays, second messenger assays, cell death assays and other assay kits. The instruments are sub-segmented into microplates, microplate reader, high throughput screening and liquid handling systems.

Technology

• Flow Cytometry
• High Throughput Screening
• High Content Screening
• Label Free Detection

On the basis of technology, the cell based assays market is segmented into flow cytometry, high throughput screening, high content screening and label free detection.

Application

• Drug Discovery
• Basic Research
• Others

On the basis of application, the cell based assays market is segmented into drug discovery, basic research and others. Drug discovery will be sub-segmented into toxicity studies, pharmacodynamics studies and pharmacokinetic studies. The drug discovery is projected to register high growth owing to the increase in the research and development investment by biopharmaceutical companies.

End User

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic and Research Institutions
• Government Organizations
• Others

On the basis of end user, the cell based assays market is bifurcated into pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, government organizations and others.

Distribution Channel

• Direct
• Indirect

On the basis of distribution channel, the cell based assays market is bifurcated into direct and indirect.

Cell Based Assays Market Regional Analysis/Insights

The cell based assays market is analyzed and market size insights and trends are provided by country, type, product and services, technology, application, end user and distribution channel as referenced above.

The countries covered in the cell based assays market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cell based assays market because of the increase in awareness about these assays for drug discovery along with the fast-paced growth in development and use of cell-based assays within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the adoption of strategic approaches such as collaborations to develop drug candidates, increasing research and developments investment by the government, and growing infrastructural development within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The cell based assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cell based assays market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cell based assays market. The data is available for historic period 2010-2020.

Competitive Landscape and Cell Based Assays Market Share Analysis

The cell based assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cell based assays market.

Some of the major players operating in the cell based assays market are Danaher (U.S), Thermo Fisher Scientific (US), Merck KGaA (Germany), BD (U.S), GE (U.S), PerkinElmer, Inc. (U.S), Promega Corporation (U.S), Charles River Laboratories (U.S), Cell Signaling Technology, Inc. (U.S), Lonza (Switzerland), BioAgilytix Labs (US), Cisbio (U.S), Reaction Biology (U.S),  Lebermuth, Inc. (U.S), Eurofins DiscoverX Products (U.S), and AAT Bioquest, Inc. (U.S) among others.

Research Methodology : Global Cell Based Assays Market

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭 다운하세요.

DBMR 연구팀이 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석, 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 남겨 업계 전문가에게 문의하세요  https://www.databridgemarketresearch.com/ko/speak-to-analyst/?dbmr=global-cell-based-assays-market

SKU-45044